Buffett's Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating
Warren Buffett stocks can teach you a thing or two about investing. Warren Buffett's annual shareholders letter to Berkshire Hathaway (NYSE: BRK-A )(NYSE: BRK-B ) investors outlines what he's done ...
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after they stop taking it.
Hot Stocks: The 3 Best Opportunities for Investing in Biotech
When it comes to risk vs. reward in the stock market, the biotech sector has one of the highest potential payoffs.
Hot Stocks: The 3 Best Opportunities for Investing in the Dow
While investing in Dow stocks – that is, the 30 companies making up the Dow Jones Industrial Average – might seem incredibly boring, investors shouldn't outright dismiss this avenue for potential p...
Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note
In the closing of the recent trading day, Amgen (AMGN) stood at $271.73, denoting a +0.31% change from the preceding trading day.
Why Amgen (AMGN) Outpaced the Stock Market Today
In the latest trading session, Amgen (AMGN) closed at $270.90, marking a +0.76% move from the previous day.
4 Oversold Large Cap Stocks Yielding High Dividends
As the market continues its relentless ascent to new heights, propelled by the surging tech sector and hype surrounding AI, the murmurs of potential interest rate cuts by the Federal Reserve conti...
Amgen Will Benefit From Increased Medical Spending
Amgen is a solid dividend growth company with a 12-year streak of raising dividends and a healthy payout ratio. The company is well-positioned to benefit from increased medical spending and the exp...
Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks
The catalyst for top weight-loss stocks comes down to one sweeping attribute: a burgeoning total addressable market. According to a Goldman Sachs analysis, earlier last year, the global industry fo...
6 Of Goldman Sachs Top 2024 Stock Picks Also Pay Big Dividends
This leading company has rallied big off the 2023 lows, pays a fat 5.18% dividend, and looks ready to break out.
Amgen (AMGN) Falls More Steeply Than Broader Market: What Investors Need to Know
In the closing of the recent trading day, Amgen (AMGN) stood at $279.35, denoting a -0.35% change from the preceding trading day.
It's Time! 3 Dodgy Pharma Stocks to Sell in February
Much like Big Tech companies ride the AI hype, pharma stocks are counting on valuation boosts from big drug hits and FDA approvals. This anticipation, however, brings to light the importance of dis...
3 Biotech Stocks to Buy and Hold for the Next 10 Years
CRISPR Therapeutics' recent major regulatory win could be the first of many. Axsome Therapeutics should ride the wave from its rich late-stage pipeline.
Amgen Inc. (AMGN) Amgen Meeting on Rare Disease (Transcript)
Amgen Inc. (NASDAQ:AMGN) Amgen Meeting on Rare Disease February 22, 2024 4:00 PM ET
Where Are Biotech ETFs Headed After Q4 Earnings?
Look into how Biotech ETFs performed after Q4 earnings.
Related Companies